APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical 3PL Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical 3PL Service Market Analysis and Forecast 2026-2032

Report ID 17421413025 January 2026190 pages

Choose your research edition.

Industry ResearchPharmaceutical 3PL Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical 3PL Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical 3PL Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical 3PL Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical 3PL Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharmaceutical 3PL Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical 3PL Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical 3PL Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical 3PL Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical 3PL Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical 3PL Service include DHL, FedEx, UPS, Kuehne+Nagel, DB Schenker, CH Robinson, CEVA Logistics, Kerry Logistics and Agility, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical 3PL Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical 3PL Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical 3PL Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical 3PL Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical 3PL Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical 3PL Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical 3PL Service Segment by Company

DHL

FedEx

UPS

Kuehne+Nagel

DB Schenker

CH Robinson

CEVA Logistics

Kerry Logistics

Agility

Expeditors International of Washington Inc.

SF Express

AmerisourceBergen Corporation

EMS

Jd.Com, Inc.

Pharmaceutical 3PL Service Segment by Type

Transportation Service

Warehousing and Storage Service

Value-added Services

Pharmaceutical 3PL Service Segment by Application

SMEs

Large Enterprise

Pharmaceutical 3PL Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical 3PL Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical 3PL Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical 3PL Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical 3PL Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical 3PL Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical 3PL Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical 3PL Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Transportation Service Major Player Table 3. Warehousing and Storage Service Major Player Table 4. Value-added Services Major Player Table 5. Global Pharmaceutical 3PL Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. SMEs Major Player Table 7. Large Enterprise Major Player Table 8. Pharmaceutical 3PL Service Industry Trends Table 9. Pharmaceutical 3PL Service Industry Drivers Table 10. Pharmaceutical 3PL Service Industry Opportunities and Challenges Table 11. Pharmaceutical 3PL Service Industry Restraints Table 12. Global Pharmaceutical 3PL Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pharmaceutical 3PL Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pharmaceutical 3PL Service Market Share by Region (2021-2026) Table 15. Global Pharmaceutical 3PL Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pharmaceutical 3PL Service Market Share by Region (2027-2032) Table 17. Global Pharmaceutical 3PL Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pharmaceutical 3PL Service Revenue Market Share by Players (2021-2026) Table 19. Global Pharmaceutical 3PL Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmaceutical 3PL Service Key Players Headquarters & Area Served Table 21. Global Pharmaceutical 3PL Service Players, Product Type & Application Table 22. Global Pharmaceutical 3PL Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmaceutical 3PL Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pharmaceutical 3PL Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical 3PL Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical 3PL Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical 3PL Service Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceutical 3PL Service Revenue Market Share by Type (2027-2032) Table 30. Global Pharmaceutical 3PL Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical 3PL Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical 3PL Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical 3PL Service Revenue Market Share by Application (2021-2026) Table 34. Global Pharmaceutical 3PL Service Revenue Market Share by Application (2027-2032) Table 35. DHL Company Information Table 36. DHL Business Overview Table 37. DHL Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. DHL Pharmaceutical 3PL Service Product Portfolio Table 39. DHL Recent Development Table 40. FedEx Company Information Table 41. FedEx Business Overview Table 42. FedEx Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. FedEx Pharmaceutical 3PL Service Product Portfolio Table 44. FedEx Recent Development Table 45. UPS Company Information Table 46. UPS Business Overview Table 47. UPS Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. UPS Pharmaceutical 3PL Service Product Portfolio Table 49. UPS Recent Development Table 50. Kuehne+Nagel Company Information Table 51. Kuehne+Nagel Business Overview Table 52. Kuehne+Nagel Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Kuehne+Nagel Pharmaceutical 3PL Service Product Portfolio Table 54. Kuehne+Nagel Recent Development Table 55. DB Schenker Company Information Table 56. DB Schenker Business Overview Table 57. DB Schenker Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. DB Schenker Pharmaceutical 3PL Service Product Portfolio Table 59. DB Schenker Recent Development Table 60. CH Robinson Company Information Table 61. CH Robinson Business Overview Table 62. CH Robinson Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. CH Robinson Pharmaceutical 3PL Service Product Portfolio Table 64. CH Robinson Recent Development Table 65. CEVA Logistics Company Information Table 66. CEVA Logistics Business Overview Table 67. CEVA Logistics Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. CEVA Logistics Pharmaceutical 3PL Service Product Portfolio Table 69. CEVA Logistics Recent Development Table 70. Kerry Logistics Company Information Table 71. Kerry Logistics Business Overview Table 72. Kerry Logistics Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Kerry Logistics Pharmaceutical 3PL Service Product Portfolio Table 74. Kerry Logistics Recent Development Table 75. Agility Company Information Table 76. Agility Business Overview Table 77. Agility Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Agility Pharmaceutical 3PL Service Product Portfolio Table 79. Agility Recent Development Table 80. Expeditors International of Washington Inc. Company Information Table 81. Expeditors International of Washington Inc. Business Overview Table 82. Expeditors International of Washington Inc. Pharmaceutical 3PL Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Expeditors International of Washington Inc. Pharmaceutical 3PL Service Product Portfolio Table 84. Expeditors International of Washington Inc. Recent Development Table 85. SF Express Company Information Table 86. SF Express Business Overview Table 87. SF Express Pharmaceutical 3PL Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. SF Express Pharmaceutical 3PL Service Product Portfolio Table 89. SF Express Recent Development Table 90. AmerisourceBergen Corporation Company Information Table 91. AmerisourceBergen Corporation Business Overview Table 92. AmerisourceBergen Corporation Pharmaceutical 3PL Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. AmerisourceBergen Corporation Pharmaceutical 3PL Service Product Portfolio Table 94. AmerisourceBergen Corporation Recent Development Table 95. EMS Company Information Table 96. EMS Business Overview Table 97. EMS Pharmaceutical 3PL Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. EMS Pharmaceutical 3PL Service Product Portfolio Table 99. EMS Recent Development Table 100. Jd.Com, Inc. Company Information Table 101. Jd.Com, Inc. Business Overview Table 102. Jd.Com, Inc. Pharmaceutical 3PL Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Jd.Com, Inc. Pharmaceutical 3PL Service Product Portfolio Table 104. Jd.Com, Inc. Recent Development Table 105. North America Pharmaceutical 3PL Service Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Pharmaceutical 3PL Service Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Pharmaceutical 3PL Service Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Pharmaceutical 3PL Service Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Pharmaceutical 3PL Service Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Pharmaceutical 3PL Service Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Pharmaceutical 3PL Service Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Pharmaceutical 3PL Service Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Pharmaceutical 3PL Service Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Pharmaceutical 3PL Service Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Pharmaceutical 3PL Service Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Pharmaceutical 3PL Service Revenue by Country (US$ Million) & (2027-2032) Table 119. China Pharmaceutical 3PL Service Revenue by Type (2021-2026) & (US$ Million) Table 120. China Pharmaceutical 3PL Service Revenue by Type (2027-2032) & (US$ Million) Table 121. China Pharmaceutical 3PL Service Revenue by Application (2021-2026) & (US$ Million) Table 122. China Pharmaceutical 3PL Service Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Pharmaceutical 3PL Service Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Pharmaceutical 3PL Service Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Pharmaceutical 3PL Service Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Pharmaceutical 3PL Service Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Pharmaceutical 3PL Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Pharmaceutical 3PL Service Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Pharmaceutical 3PL Service Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Pharmaceutical 3PL Service Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Pharmaceutical 3PL Service Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Pharmaceutical 3PL Service Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Pharmaceutical 3PL Service Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Pharmaceutical 3PL Service Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Pharmaceutical 3PL Service Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Pharmaceutical 3PL Service Image Figure 2. Global Pharmaceutical 3PL Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical 3PL Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Transportation Service Image Figure 5. Warehousing and Storage Service Image Figure 6. Value-added Services Image Figure 7. Global Pharmaceutical 3PL Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pharmaceutical 3PL Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. SMEs Image Figure 10. Large Enterprise Image Figure 11. Global Pharmaceutical 3PL Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Pharmaceutical 3PL Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical 3PL Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical 3PL Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pharmaceutical 3PL Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceutical 3PL Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical 3PL Service Revenue Market Share by Type (2021-2032) Figure 19. Global Pharmaceutical 3PL Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmaceutical 3PL Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pharmaceutical 3PL Service Revenue Market Share by Application (2021-2032) Figure 22. North America Pharmaceutical 3PL Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical 3PL Service Revenue Share by Type (2021-2032) Figure 24. North America Pharmaceutical 3PL Service Revenue Share by Application (2021-2032) Figure 25. North America Pharmaceutical 3PL Service Revenue Share by Country (2021-2032) Figure 26. United States Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pharmaceutical 3PL Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pharmaceutical 3PL Service Revenue Share by Type (2021-2032) Figure 31. Europe Pharmaceutical 3PL Service Revenue Share by Application (2021-2032) Figure 32. Europe Pharmaceutical 3PL Service Revenue Share by Country (2021-2032) Figure 33. Germany Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pharmaceutical 3PL Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical 3PL Service Revenue Share by Type (2021-2032) Figure 43. China Pharmaceutical 3PL Service Revenue Share by Application (2021-2032) Figure 44. Asia Pharmaceutical 3PL Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pharmaceutical 3PL Service Revenue Share by Type (2021-2032) Figure 46. Asia Pharmaceutical 3PL Service Revenue Share by Application (2021-2032) Figure 47. Asia Pharmaceutical 3PL Service Revenue Share by Region (2021-2032) Figure 48. Japan Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pharmaceutical 3PL Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pharmaceutical 3PL Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Pharmaceutical 3PL Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Pharmaceutical 3PL Service Revenue Share by Country (2021-2032) Figure 58. Brazil Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pharmaceutical 3PL Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Transportation Service
  • Warehousing and Storage Service
  • Value-added Services
Applications
  • SMEs
  • Large Enterprise
Companies covered
  • DHL
  • FedEx
  • UPS
  • Kuehne+Nagel
  • DB Schenker
  • CH Robinson
  • CEVA Logistics
  • Kerry Logistics
  • Agility
  • Expeditors International of Washington Inc.
  • SF Express
  • AmerisourceBergen Corporation
  • EMS
  • Jd.Com, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical 3PL Service Market by Type
  3. 1.2.1 Global Pharmaceutical 3PL Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Transportation Service
  5. 1.2.3 Warehousing and Storage Service
  6. 1.2.4 Value-added Services
  7. 1.3 Pharmaceutical 3PL Service Market by Application
  8. 1.3.1 Global Pharmaceutical 3PL Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 SMEs
  10. 1.3.3 Large Enterprise
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pharmaceutical 3PL Service Market Dynamics
  1. 2.1 Pharmaceutical 3PL Service Industry Trends
  2. 2.2 Pharmaceutical 3PL Service Industry Drivers
  3. 2.3 Pharmaceutical 3PL Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical 3PL Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical 3PL Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical 3PL Service Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical 3PL Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical 3PL Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical 3PL Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical 3PL Service Revenue by Players
  2. 4.1.1 Global Pharmaceutical 3PL Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical 3PL Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical 3PL Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical 3PL Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical 3PL Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical 3PL Service Players, Product Type & Application
  8. 4.5 Global Pharmaceutical 3PL Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical 3PL Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical 3PL Service Tier 1, Tier 2, and Tier 3
5 Pharmaceutical 3PL Service Market Size by Type
  1. 5.1 Global Pharmaceutical 3PL Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical 3PL Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical 3PL Service Revenue Market Share by Type (2021-2032)
6 Pharmaceutical 3PL Service Market Size by Application
  1. 6.1 Global Pharmaceutical 3PL Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical 3PL Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical 3PL Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 DHL
  2. 7.1.1 DHL Company Information
  3. 7.1.2 DHL Business Overview
  4. 7.1.3 DHL Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 DHL Pharmaceutical 3PL Service Product Portfolio
  6. 7.1.5 DHL Recent Developments
  7. 7.2 FedEx
  8. 7.2.1 FedEx Company Information
  9. 7.2.2 FedEx Business Overview
  10. 7.2.3 FedEx Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 FedEx Pharmaceutical 3PL Service Product Portfolio
  12. 7.2.5 FedEx Recent Developments
  13. 7.3 UPS
  14. 7.3.1 UPS Company Information
  15. 7.3.2 UPS Business Overview
  16. 7.3.3 UPS Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 UPS Pharmaceutical 3PL Service Product Portfolio
  18. 7.3.5 UPS Recent Developments
  19. 7.4 Kuehne+Nagel
  20. 7.4.1 Kuehne+Nagel Company Information
  21. 7.4.2 Kuehne+Nagel Business Overview
  22. 7.4.3 Kuehne+Nagel Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Kuehne+Nagel Pharmaceutical 3PL Service Product Portfolio
  24. 7.4.5 Kuehne+Nagel Recent Developments
  25. 7.5 DB Schenker
  26. 7.5.1 DB Schenker Company Information
  27. 7.5.2 DB Schenker Business Overview
  28. 7.5.3 DB Schenker Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 DB Schenker Pharmaceutical 3PL Service Product Portfolio
  30. 7.5.5 DB Schenker Recent Developments
  31. 7.6 CH Robinson
  32. 7.6.1 CH Robinson Company Information
  33. 7.6.2 CH Robinson Business Overview
  34. 7.6.3 CH Robinson Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CH Robinson Pharmaceutical 3PL Service Product Portfolio
  36. 7.6.5 CH Robinson Recent Developments
  37. 7.7 CEVA Logistics
  38. 7.7.1 CEVA Logistics Company Information
  39. 7.7.2 CEVA Logistics Business Overview
  40. 7.7.3 CEVA Logistics Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CEVA Logistics Pharmaceutical 3PL Service Product Portfolio
  42. 7.7.5 CEVA Logistics Recent Developments
  43. 7.8 Kerry Logistics
  44. 7.8.1 Kerry Logistics Company Information
  45. 7.8.2 Kerry Logistics Business Overview
  46. 7.8.3 Kerry Logistics Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kerry Logistics Pharmaceutical 3PL Service Product Portfolio
  48. 7.8.5 Kerry Logistics Recent Developments
  49. 7.9 Agility
  50. 7.9.1 Agility Company Information
  51. 7.9.2 Agility Business Overview
  52. 7.9.3 Agility Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Agility Pharmaceutical 3PL Service Product Portfolio
  54. 7.9.5 Agility Recent Developments
  55. 7.10 Expeditors International of Washington Inc.
  56. 7.10.1 Expeditors International of Washington Inc. Company Information
  57. 7.10.2 Expeditors International of Washington Inc. Business Overview
  58. 7.10.3 Expeditors International of Washington Inc. Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Expeditors International of Washington Inc. Pharmaceutical 3PL Service Product Portfolio
  60. 7.10.5 Expeditors International of Washington Inc. Recent Developments
  61. 7.11 SF Express
  62. 7.11.1 SF Express Company Information
  63. 7.11.2 SF Express Business Overview
  64. 7.11.3 SF Express Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 SF Express Pharmaceutical 3PL Service Product Portfolio
  66. 7.11.5 SF Express Recent Developments
  67. 7.12 AmerisourceBergen Corporation
  68. 7.12.1 AmerisourceBergen Corporation Company Information
  69. 7.12.2 AmerisourceBergen Corporation Business Overview
  70. 7.12.3 AmerisourceBergen Corporation Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AmerisourceBergen Corporation Pharmaceutical 3PL Service Product Portfolio
  72. 7.12.5 AmerisourceBergen Corporation Recent Developments
  73. 7.13 EMS
  74. 7.13.1 EMS Company Information
  75. 7.13.2 EMS Business Overview
  76. 7.13.3 EMS Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 EMS Pharmaceutical 3PL Service Product Portfolio
  78. 7.13.5 EMS Recent Developments
  79. 7.14 Jd.Com, Inc.
  80. 7.14.1 Jd.Com, Inc. Company Information
  81. 7.14.2 Jd.Com, Inc. Business Overview
  82. 7.14.3 Jd.Com, Inc. Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Jd.Com, Inc. Pharmaceutical 3PL Service Product Portfolio
  84. 7.14.5 Jd.Com, Inc. Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical 3PL Service Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical 3PL Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical 3PL Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical 3PL Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical 3PL Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical 3PL Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical 3PL Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical 3PL Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical 3PL Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical 3PL Service Revenue by Country
  11. 8.6.1 North America Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical 3PL Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical 3PL Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical 3PL Service Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical 3PL Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical 3PL Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical 3PL Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical 3PL Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical 3PL Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical 3PL Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical 3PL Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical 3PL Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical 3PL Service Revenue by Country
  11. 9.6.1 Europe Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical 3PL Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical 3PL Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical 3PL Service Revenue (2021-2032)
  2. 10.2 China Pharmaceutical 3PL Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical 3PL Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical 3PL Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical 3PL Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical 3PL Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical 3PL Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical 3PL Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical 3PL Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical 3PL Service Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical 3PL Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical 3PL Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical 3PL Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical 3PL Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical 3PL Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical 3PL Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical 3PL Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical 3PL Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical 3PL Service Revenue by Country
  11. 11.6.1 Asia Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical 3PL Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical 3PL Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical 3PL Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical 3PL Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical 3PL Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical 3PL Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical 3PL Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical 3PL Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical 3PL Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical 3PL Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical 3PL Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical 3PL Service Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical 3PL Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical 3PL Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical 3PL Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst